Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

Name: Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Published: 2008
License: Public Domain

National Cancer Institute (NCI) · 2008

ClinicalTrials.gov · Datasets · License: Public Domain · 2008

Open Source ↗

acute-myeloid-leukemia

acute myeloid leukemia, adult acute megakaryoblastic leukemia (m7), adult acute minimally differentiated myeloid leukemia (m0), adult acute monoblastic leukemia (m5a), adult acute monocytic leukemia (m5b), adult acute myeloblastic leukemia with maturation (m2), adult acute myeloblastic leukemia without maturation (m1), adult acute myeloid leukemia with 11q23 (mll) abnormalities, adult acute myeloid leukemia with inv(16)(p13;q22), adult acute myeloid leukemia with t(16;16)(p13;q22), adult acute myeloid leukemia with t(8;21)(q22;q22), adult acute myelomonocytic leukemia (m4)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 904089
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.